Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionPrice T Rowe Associates Inc /md/
Latest Disclosed Ownership149,821 shares
Latest Disclosed Value $ 342
Price T Rowe Associates Inc /md/ reports 11.46% increase in ownership of 9EH / Evolent Health, Inc.

On May 15, 2026 - Price T Rowe Associates Inc /md/ filed a 13F-HR form disclosing ownership of 149,821 shares of Evolent Health, Inc. (DE:9EH) valued at $283,162 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 134,413 shares of Evolent Health, Inc.. The current value of the position is $506,395 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EVOLENT HEALTH COMM STK 30050B101 149,821 15,408 11.46 0 0.0000
2026-02-17 2025-12-31 13F EVOLENT HEALTH COMM STK 30050B101 134,413 18,653 16.11 1 0.0001
2025-11-14 2025-09-30 13F EVOLENT HEALTH COMM STK 30050B101 115,760 9,998 9.45 1 -100.00 0.0001
2025-08-14 2025-06-30 13F EVOLENT HEALTH COMM STK 30050B101 105,762 7,156 7.26 1 0.0001
2025-05-14 2025-03-31 13F EVOLENT HEALTH COMM STK 30050B101 98,606 -645,839 -86.75 1 -100.00 0.0001
2025-02-14 2024-12-31 13F EVOLENT HEALTH COMM STK 30050B101 744,445 28,540 3.99 8 -60.00 0.0010
2024-11-14 2024-09-30 13F EVOLENT HEALTH COMM STK 30050B101 715,905 -7,054 -0.98 20 53.85 0.0023
2024-08-14 2024-06-30 13F EVOLENT HEALTH COMM STK 30050B101 722,959 5,625 0.78 14 -43.48 0.0017
2024-05-15 2024-03-31 13F EVOLENT HEALTH COMM STK 30050B101 717,334 75,376 11.74 24 9.52 0.0029
2024-02-16 2023-12-31 13F/A-1 EVOLENT HEALTH COMM STK 30050B101 641,958 4,080 0.64 21 23.53 0.0028
2024-02-14 2023-12-31 13F EVOLENT HEALTH COMM STK 30050B101 641,958 4,080 21 0.0014
2023-11-14 2023-09-30 13F EVOLENT HEALTH COMM STK 30050B101 637,878 -212,383 -24.98 17 -32.00 0.0025
2023-08-14 2023-06-30 13F EVOLENT HEALTH COMM STK 30050B101 850,261 6,317 0.75 26 -7.41 0.0036
2023-05-15 2023-03-31 13F EVOLENT HEALTH COMM STK 30050B101 843,944 -3,185 -0.38 27 17.39 0.0041
2023-02-14 2022-12-31 13F EVOLENT HEALTH COMM STK 30050B101 847,129 94,043 12.49 24 -99.92 0.0038
2022-11-14 2022-09-30 13F EVOLENT HEALTH COMM STK 30050B101 753,086 715,327 1,894.45 27,060 2,232.76 0.0044
2022-08-15 2022-06-30 13F EVOLENT HEALTH COMM STK 30050B101 37,759 3,382 9.84 1,160 4.50 0.0001
2022-05-16 2022-03-31 13F EVOLENT HEALTH COMM STK 30050B101 34,377 4,340 14.45 1,110 33.57 0.0001
2022-02-14 2021-12-31 13F EVOLENT HEALTH COMM STK 30050B101 30,037 -5,035 -14.36 831 -23.55 0.0001
2021-11-15 2021-09-30 13F EVOLENT HEALTH COMM STK 30050B101 35,072 -1,500 -4.10 1,087 40.80 0.0001
2021-08-16 2021-06-30 13F EVOLENT HEALTH COMM STK 30050B101 36,572 -661 -1.78 772 2.66 0.0001
2021-05-17 2021-03-31 13F EVOLENT HEALTH COMM STK 30050B101 37,233 -3,971 -9.64 752 13.77 0.0001
2021-02-16 2020-12-31 13F EVOLENT HEALTH COMM STK 30050B101 41,204 7,900 23.72 661 60.05 0.0001
2020-11-16 2020-09-30 13F EVOLENT HEALTH COMM STK 30050B101 33,304 -19,100 -36.45 413 10.72 0.0000
2020-08-14 2020-06-30 13F EVOLENT HEALTH COMM STK 30050B101 52,404 -4,438 -7.81 373 20.71 0.0000
2020-05-15 2020-03-31 13F EVOLENT HEALTH COMM STK 30050B101 56,842 787 1.40 309 -39.05 0.0000
2020-02-14 2019-12-31 13F EVOLENT HEALTH COMM STK 30050B101 56,055 36,482 186.39 507 259.57 0.0001
2019-11-14 2019-09-30 13F EVOLENT HEALTH COMM STK 30050B101 19,573 362 1.88 141 -7.84 0.0000
2019-08-15 2019-06-30 13F EVOLENT HEALTH COMM STK 30050B101 19,211 310 1.64 153 -35.71 0.0000
2019-05-15 2019-03-31 13F EVOLENT HEALTH COMM STK 30050B101 18,901 200 1.07 238 -36.19 0.0000
2019-02-14 2018-12-31 13F EVOLENT HEALTH COMM STK 30050B101 18,701 328 1.79 373 -28.54 0.0001
2018-11-14 2018-09-30 13F EVOLENT HEALTH COMM STK 30050B101 18,373 597 3.36 522 39.57 0.0001
2018-08-14 2018-06-30 13F EVOLENT HEALTH COMM STK 30050B101 17,776 -5,077 -22.22 374 14.72 0.0001
2018-05-14 2018-03-31 13F EVOLENT HEALTH COMM STK 30050B101 22,853 285 1.26 326 17.27 0.0001
2018-02-14 2017-12-31 13F EVOLENT HEALTH COMM STK 30050B101 22,568 6,760 42.76 278 -1.07 0.0000
2017-11-14 2017-09-30 13F EVOLENT HEALTH COMM STK 30050B101 15,808 100 0.64 281 -29.40 0.0000
2017-08-14 2017-06-30 13F EVOLENT HEALTH COMM STK 30050B101 15,708 -936 -5.62 398 7.28 0.0001
2017-05-15 2017-03-31 13F EVOLENT HEALTH COMM STK 30050B101 16,644 13 0.08 371 50.81 0.0001
2017-02-14 2016-12-31 13F EVOLENT HEALTH COMM STK 30050B101 16,631 16,631 246 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.